SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001607062-17-000126
Filing Date
2017-03-30
Accepted
2017-03-30 17:15:55
Documents
62
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A rgbp033116form10qa.htm 10-Q/A 735150
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9969
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9827
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5701
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 5496
  Complete submission text file 0001607062-17-000126.txt   3571839

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rgbp-20160331.xml EX-101.INS 657613
7 XBRL SCHEMA FILE rgbp-20160331.xsd EX-101.SCH 33386
8 XBRL CALCULATION FILE rgbp-20160331_cal.xml EX-101.CAL 34675
9 XBRL DEFINITION FILE rgbp-20160331_def.xml EX-101.DEF 186205
10 XBRL LABEL FILE rgbp-20160331_lab.xml EX-101.LAB 160495
11 XBRL PRESENTATION FILE rgbp-20160331_pre.xml EX-101.PRE 218767
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 333-191725 | Film No.: 17726857
SIC: 2834 Pharmaceutical Preparations